CEO, Navier Medical Ltd
| Role | Organisation | Sources |
|---|---|---|
| CEO | Navier Medical Ltd | Dealroom |
Stories naming Sander Bangma. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Six Australian health tech startups received non-dilutive grants totaling $13.5 million from the government-backed CUREator+ program to accelerate commercialisation of medical innovations.
Six Australian biomedical and health ventures receive a combined $13.5 million in non-dilutive grants through round two of the CUREator+ commercialisation program operated by Brandon BioCatalyst and backed by the Medical Research Future Fund.
Also Dealroom
Six Australian health tech startups received a combined $13.5 million in non-dilutive funding from the CUREator+ program, supported by the Australian Government.
CUREator+ granted thirteen point five million dollars in non-dilutive funding to six Australian health tech startups to support commercialisation of medical innovations.
ANDHealth announced its fourth accelerator cohort, granting non-dilutive MRFF funding to six digital health startups including Cape Bionics and Healthily to support commercialisation.